@article{ART002523523},
author={Na-Ra Han and Hyung-Min Kim},
title={Depression, what should we be doing?},
journal={CELLMED},
issn={3022-6805},
year={2019},
volume={9},
number={2},
pages={2-2}
TY - JOUR
AU - Na-Ra Han
AU - Hyung-Min Kim
TI - Depression, what should we be doing?
JO - CELLMED
PY - 2019
VL - 9
IS - 2
PB - Cellmed Orthocellular Medicine and Pharmaceutical Association
SP - 2
EP - 2
SN - 3022-6805
AB - Depression is common psychiatric diseases characterized by diverse physical and emotional symptoms including low mood, loss of interest in pleasurable activities, and feelings of worthlessness. Depression causes of death and disability. The first antidepressant was created by the idea that central serotonin mechanism. Selective serotonin reuptake inhibitor, fluoxetine is the first-line drug in the treatment of depressive disorder and their few side effects as opposed to tricyclic antidepressants. Not all people with depression respond adequately to standard treatments. Korean music playing/listening actions appear to be a reliable approach to developing recovery from depression.
KW - depression;Korean music playing/listening
DO -
UR -
ER -
Na-Ra Han and Hyung-Min Kim. (2019). Depression, what should we be doing?. CELLMED, 9(2), 2-2.
Na-Ra Han and Hyung-Min Kim. 2019, "Depression, what should we be doing?", CELLMED, vol.9, no.2 pp.2-2.
Na-Ra Han, Hyung-Min Kim "Depression, what should we be doing?" CELLMED 9.2 pp.2-2 (2019) : 2.
Na-Ra Han, Hyung-Min Kim. Depression, what should we be doing?. 2019; 9(2), 2-2.
Na-Ra Han and Hyung-Min Kim. "Depression, what should we be doing?" CELLMED 9, no.2 (2019) : 2-2.
Na-Ra Han; Hyung-Min Kim. Depression, what should we be doing?. CELLMED, 9(2), 2-2.
Na-Ra Han; Hyung-Min Kim. Depression, what should we be doing?. CELLMED. 2019; 9(2) 2-2.
Na-Ra Han, Hyung-Min Kim. Depression, what should we be doing?. 2019; 9(2), 2-2.
Na-Ra Han and Hyung-Min Kim. "Depression, what should we be doing?" CELLMED 9, no.2 (2019) : 2-2.
